Gene · 10189
Papers1,565
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,565
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LENG8 mediates RNA nuclear retention and degradation in eukaryotes. | bioRxiv | 2025 | 40832163 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of EXOSC family genes in head and neck squamous cell carcinoma. | Sci Rep | 2025 | 40830179 | PubTator, text mining | PubMed |
| A time-resolved framework for the recruitment of mRNP processing and assembly factors to a site of transcription. | Nucleic Acids Res | 2025 | 40823808 | PubTator, text mining | PubMed |
| NSUN2 promotes colorectal cancer progression by stabilizing PHGDH mRNA to promote serine metabolism reprogramming. | Cancer Metab | 2025 | 40814066 | PubTator, text mining | PubMed |
| The role of m5C, m1A and m7G modifications in tumors of urinary system. | Front Cell Dev Biol | 2025 | 40809690 | PubTator, text mining | PubMed |
| RNA-interactome capture identifies SRSF3 as a key protein for herpesviral gene expression. | PNAS Nexus | 2025 | 40809086 | PubTator, text mining | PubMed |
| Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. | Signal Transduct Target Ther | 2025 | 40804047 | PubTator, text mining | PubMed |
| RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications. | MedComm (2020) | 2025 | 40761481 | PubTator, text mining | PubMed |
| Revealing the causal relationship between cathepsin and inflammatory disease of wrist through Mendelian randomization. | Medicine (Baltimore) | 2025 | 40760539 | PubTator, text mining | PubMed |
| Epitranscriptomic alterations induced by environmental toxins: implications for RNA modifications and disease. | Genes Environ | 2025 | 40760453 | PubTator, text mining | PubMed |
| Proteomic analysis of tumor cell nuclear expulsion reveals significant cell adhesion and RNA binding programs in extracellular chromatin. | Sci Rep | 2025 | 40751052 | PubTator, text mining | PubMed |
| Impact on the Leishmania mexicana transcriptome due to knockout of genes encoding orthologs of methyltransferases involved in m1A and m5C mRNA modifications. | Parasit Vectors | 2025 | 40745619 | PubTator, text mining | PubMed |
| M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges. | Front Oncol | 2025 | 40740874 | PubTator, text mining | PubMed |
| Regulation and intervention of stem cell differentiation by long non-coding RNAs: Mechanisms and therapeutic potential. | World J Stem Cells | 2025 | 40740526 | PubTator, text mining | PubMed |
| NSUN2-mediated RNA m5C modification drives multiple myeloma progression by enhancing the stability of HIP1 mRNA. | Sci Rep | 2025 | 40739289 | PubTator, text mining | PubMed |
| Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC. | Breast Cancer Res | 2025 | 40731028 | PubTator, text mining | PubMed |
| NSUN5 accelerates the progression of liver hepatocellular carcinoma by m5C-EFNA3-mediated glycolysis. | BMC Cancer | 2025 | 40730949 | PubTator, text mining | PubMed |
| Copy number amplification of TTPAL promotes cholesterol biosynthesis and esophageal squamous cell carcinoma progression via elevating NSUN2-mediated m5C modification of SREBP2 mRNA. | J Exp Clin Cancer Res | 2025 | 40713894 | PubTator, text mining | PubMed |
| Identification and validation of a prognostic signature of m5C-related genes for esophageal cancer. | J Thorac Dis | 2025 | 40688336 | PubTator, text mining | PubMed |
| The role of exosomes in immunopathology and potential therapeutic implications. | Cell Mol Immunol | 2025 | 40659888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10189/papers?page=4